OABI FY 2021 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+49.3% YoY

Gross Profit

$35M100.0% margin

Operating Income

-$36M-102.5% margin

Net Income

-$27M-77.8% margin

EPS (Diluted)

$-0.24

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$10M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$304M

Total Liabilities

$70M

Stockholders' Equity

$234M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$23M	+49.3%
Gross Profit	$35M	$23M	+49.3%
Operating Income	-$36M	-$26M	-39.0%
Net Income	-$27M	-$18M	-54.0%